牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

昭衍新药（603127）

4.7

综合诊断：4.7分打败了41%的股票！

卖出
减持
中性
增持
买入

短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
中期趋势：
-
长期趋势：
已有115家主力机构披露2024-12-31报告期持股数据，持仓量总计6621.27万股，占流通A股10.50%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

3.7分

4.8分

5.5分

3.5分

5.8分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：3.7技术面打败了41%的股票技术面评分前10的股票

近期的平均成本为15.90元。

技术面得分最高的股票

平均成本

近期的平均成本为15.90元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"15.90","date":1747628374,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势接近大盘，接近行业平均水平。

[{"date":"2025.05.19","stock":"0.88","trade":"0.14","ind":"0.00"},{"date":"2025.05.16","stock":"0.32","trade":"0.07","ind":"-0.40"},{"date":"2025.05.15","stock":"-1.68","trade":"-1.06","ind":"-0.68"},{"date":"2025.05.14","stock":"-0.92","trade":"-0.09","ind":"0.86"},{"date":"2025.05.13","stock":"1.69","trade":"1.59","ind":"0.17"},{"date":"2025.05.12","stock":"-1.12","trade":"0.93","ind":"0.82"},{"date":"2025.05.09","stock":"-1.35","trade":"-1.57","ind":"-0.30"},{"date":"2025.05.08","stock":"2.89","trade":"1.03","ind":"0.28"},{"date":"2025.05.07","stock":"-1.00","trade":"-0.02","ind":"0.80"},{"date":"2025.05.06","stock":"2.95","trade":"3.02","ind":"1.13"},{"date":"2025.04.30","stock":"0.65","trade":"0.54","ind":"-0.23"},{"date":"2025.04.29","stock":"1.51","trade":"1.57","ind":"-0.05"},{"date":"2025.04.28","stock":"-1.80","trade":"-1.56","ind":"-0.20"},{"date":"2025.04.25","stock":"0.65","trade":"0.26","ind":"-0.07"},{"date":"2025.04.24","stock":"-0.96","trade":"0.18","ind":"0.03"},{"date":"2025.04.23","stock":"-0.38","trade":"0.02","ind":"-0.10"},{"date":"2025.04.22","stock":"0.26","trade":"-0.69","ind":"0.25"},{"date":"2025.04.21","stock":"0.58","trade":"1.67","ind":"0.45"},{"date":"2025.04.18","stock":"0.45","trade":"0.31","ind":"-0.11"},{"date":"2025.04.17","stock":"0.06","trade":"0.53","ind":"0.13"},{"date":"2025.04.16","stock":"-4.51","trade":"-2.42","ind":"0.26"}]

昭衍新药,上证指数,医疗服务指数

压力支撑

该股压力位为15.82元，支撑位为15.61元。

[{"text":"\u538b\u529b\u4f4d","value":"15.82","date":1747584000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"15.61","date":1747584000,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.8资金面打败了61%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医疗服务行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：05月20日 12:43

机构今日流向(万元)	-601.81	机构5日流向(万元)	-2343.88
机构10日流向(万元)	-7423.58	机构20日流向(万元)	-12144.48

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量增加353.93万股，其中基金净减仓5家，主力净减仓24家，暂未发现中长期投资价值。

截止2024-12-31，共115家主力机构（基金113家，一般法人1家，券商集合理财1家），持仓量总计6621.27万股，占流通A股10.50%
其中，基金持仓与2024-06-30相比：
增仓：19家，增持 404.10万股
减仓：24家，减持 207.73万股
新出现在主力名单中：61家，持有2178.68万股
从主力名单中消失：85家，原持有2036.53万股

消息面诊股

诊断结果：5.5消息面打败了49%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

利好	分红转增	10派0.3元(含税)	2025-03-29
一般消息	重大事项	关联交易	2025-03-29
重大利空	业绩预告	业绩大幅下降	2025-01-25
一般消息	高管变动	连续担任公司独立董事期限即将满六年	2025-01-23
一般消息	股东大会	临时股东大会	2025-01-04
一般消息	重大事项	关联交易	2024-12-21
一般消息	高管变动	个人及工作原因	2024-12-20
一般消息	高管变动	因个人及工作原因	2024-10-30
一般消息	分红转增	不分配不转增	2024-08-31
一般消息	重大事项	关联交易	2024-08-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	1条	1条	0条

行业面诊股

诊断结果：3.5行业面打败了32%的股票医疗服务行业最新资金流向

近10日来该行业走势不明显，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.05.19","price":"0.00","value":"0.14"},{"date":"2025.05.16","price":"-0.40","value":"0.07"},{"date":"2025.05.15","price":"-0.68","value":"-1.06"},{"date":"2025.05.14","price":"0.86","value":"-0.09"},{"date":"2025.05.13","price":"0.17","value":"1.59"},{"date":"2025.05.12","price":"0.82","value":"0.93"},{"date":"2025.05.09","price":"-0.30","value":"-1.57"},{"date":"2025.05.08","price":"0.28","value":"1.03"},{"date":"2025.05.07","price":"0.80","value":"-0.02"},{"date":"2025.05.06","price":"1.13","value":"3.02"},{"date":"2025.04.30","price":"-0.23","value":"0.54"},{"date":"2025.04.29","price":"-0.05","value":"1.57"},{"date":"2025.04.28","price":"-0.20","value":"-1.56"},{"date":"2025.04.25","price":"-0.07","value":"0.26"},{"date":"2025.04.24","price":"0.03","value":"0.18"},{"date":"2025.04.23","price":"-0.10","value":"0.02"},{"date":"2025.04.22","price":"0.25","value":"-0.69"},{"date":"2025.04.21","price":"0.45","value":"1.67"},{"date":"2025.04.18","price":"-0.11","value":"0.31"},{"date":"2025.04.17","price":"0.13","value":"0.53"},{"date":"2025.04.16","price":"0.26","value":"-2.42"}]

上证指数,医疗服务行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	金凯生科	36.18%	-7.19%	5.0分
2	凯莱英	29.34%	-0.43%	5.0分
3	华康洁净	22.95%	2.39%	5.5分
4	药明康德	16.60%	2.76%	5.5分
5	澳洋健康	15.99%	1.09%	5.1分
6	何氏眼科	15.86%	2.34%	5.2分
7	ST中珠	14.84%	9.70%	6.4分
8	泓博医药	12.88%	1.01%	4.8分
9	睿智医药	12.59%	1.93%	5.5分
10	创新医疗	11.96%	2.62%	5.0分
11	华大基因	11.55%	6.47%	4.9分
12	皓元医药	11.30%	-2.52%	5.3分
13	百花医药	10.94%	1.69%	5.6分
14	博腾股份	9.75%	0.27%	4.4分
15	海特生物	9.59%	1.78%	4.8分
16	兰卫医学	8.27%	1.62%	4.9分
17	奥浦迈	8.21%	3.51%	5.2分
18	药康生物	7.96%	-0.83%	5.2分
19	美迪西	7.86%	-1.17%	4.8分
20	皓宸医疗	7.84%	0.36%	5.3分
21	南模生物	7.76%	1.43%	5.2分
22	迪安诊断	7.39%	1.10%	5.0分
23	金域医学	7.26%	-1.43%	5.1分
24	毕得医药	7.22%	0.07%	5.3分
25	成都先导	7.10%	-1.30%	4.5分
26	九洲药业	5.61%	1.44%	5.3分
27	光正眼科	5.60%	1.97%	5.3分
28	百诚医药	5.28%	-0.69%	3.8分
29	新里程	4.85%	3.48%	5.2分
30	药石科技	4.71%	-2.56%	4.0分
31	阳光诺和	4.18%	3.57%	5.8分
32	和元生物	4.01%	0.18%	4.4分
33	昭衍新药	3.56%	0.25%	4.7分
34	贝瑞基因	3.47%	5.59%	4.7分
35	盈康生命	3.09%	-1.48%	5.0分
36	万邦医药	2.95%	2.21%	4.3分
37	诺禾致源	2.83%	-2.26%	4.8分
38	华厦眼科	2.66%	-2.27%	4.9分
39	普蕊斯	2.57%	-0.85%	4.4分
40	诺思格	2.57%	-1.73%	4.5分
41	诚达药业	1.13%	0.84%	4.6分
42	康龙化成	0.90%	-4.07%	5.2分
43	三博脑科	-0.18%	1.37%	5.3分
44	国际医学	-0.38%	0.78%	5.0分
45	美年健康	-0.38%	-0.93%	5.7分
46	普瑞眼科	-0.63%	-3.84%	4.7分
47	爱尔眼科	-0.70%	-1.62%	5.0分
48	益诺思	-1.58%	-1.21%	4.3分
49	泰格医药	-2.52%	-4.86%	4.4分
50	通策医疗	-4.43%	-0.88%	5.3分
51	博济医药	-7.43%	-1.08%	4.0分
52	*ST生物	-21.45%	5.07%	5.0分
53	-	-	153.01%	分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：5.8基本面打败了46%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2025-03-31 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 31/98 ， 34/98。

[{"date":"2025-03-31","value":"0.51","vol":"1.01"},{"date":"2024-12-31","value":"0.91","vol":"-0.15"},{"date":"2024-09-30","value":"-0.86","vol":"3.24"},{"date":"2024-06-30","value":"-2.10","vol":"2.52"},{"date":"2024-03-31","value":"-3.35","vol":"1.10"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净资产收益率(%)	0.51	0.91	-0.86	-2.10	-3.35
行业(%)	1.01	-0.15	3.24	2.52	1.10

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"28.61","vol":"34.88"},{"date":"2024-12-31","value":"28.43","vol":"34.77"},{"date":"2024-09-30","value":"27.48","vol":"36.16"},{"date":"2024-06-30","value":"30.37","vol":"36.37"},{"date":"2024-03-31","value":"32.84","vol":"36.30"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
销售毛利率(%)	28.61	28.43	27.48	30.37	32.84
行业(%)	34.88	34.77	36.16	36.37	36.30

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 36/98 ， 5/98。

[{"date":"2025-03-31","value":"-11.54","vol":"-0.03"},{"date":"2024-12-31","value":"-15.07","vol":"-0.73"},{"date":"2024-09-30","value":"-15.87","vol":"0.87"},{"date":"2024-06-30","value":"-16.08","vol":"0.65"},{"date":"2024-03-31","value":"-12.07","vol":"3.42"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
营业收入同比增长率(%)	-11.54	-15.07	-15.87	-16.08	-12.07
行业(%)	-0.03	-0.73	0.87	0.65	3.42

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"115.11","vol":"-26.52"},{"date":"2024-12-31","value":"-81.34","vol":"-96.53"},{"date":"2024-09-30","value":"-121.46","vol":"-161.08"},{"date":"2024-06-30","value":"-287.30","vol":"-107.95"},{"date":"2024-03-31","value":"-244.98","vol":"-51.89"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净利润同比增长率(%)	115.11	-81.34	-121.46	-287.30	-244.98
行业(%)	-26.52	-96.53	-161.08	-107.95	-51.89

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 50/98 ， 50/98。

[{"date":"2025-03-31","value":"0.03","vol":"0.10"},{"date":"2024-12-31","value":"0.21","vol":"0.41"},{"date":"2024-09-30","value":"0.14","vol":"0.31"},{"date":"2024-06-30","value":"0.09","vol":"0.20"},{"date":"2024-03-31","value":"0.03","vol":"0.10"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
总资产周转率(次)	0.03	0.21	0.14	0.09	0.03
行业(次)	0.10	0.41	0.31	0.20	0.10

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.14","vol":"3.70"},{"date":"2024-12-31","value":"0.86","vol":"16.35"},{"date":"2024-09-30","value":"0.55","vol":"14.25"},{"date":"2024-06-30","value":"0.34","vol":"8.86"},{"date":"2024-03-31","value":"0.12","vol":"4.59"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
存货增长率(次)	0.14	0.86	0.55	0.34	0.12
行业(次)	3.70	16.35	14.25	8.86	4.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-03-31","value":"22.67","vol":"-1.20"},{"date":"2024-12-31","value":"21.46","vol":"22.34"},{"date":"2024-09-30","value":"7.12","vol":"12.23"},{"date":"2024-06-30","value":"7.20","vol":"9.92"},{"date":"2024-03-31","value":"36.93","vol":"0.21"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
现金流量净额/营业收入	22.67	21.46	7.12	7.20	36.93
行业	-1.20	22.34	12.23	9.92	0.21

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.82","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.79","vol":"1.44"},{"date":"2024-03-31","value":"","vol":"0.00"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资本支出／折旧和摊销	-	1.82	-	1.79	-
行业	0.00	1.31	0.00	1.44	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 39/98 ， 32/98。

[{"date":"2025-03-31","value":"4.61","vol":"3.90"},{"date":"2024-12-31","value":"4.53","vol":"3.70"},{"date":"2024-09-30","value":"4.11","vol":"4.11"},{"date":"2024-06-30","value":"3.62","vol":"4.14"},{"date":"2024-03-31","value":"4.64","vol":"4.40"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
流动比率	4.61	4.53	4.11	3.62	4.64
行业	3.90	3.70	4.11	4.14	4.40

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"2.26","vol":"3.17"},{"date":"2024-12-31","value":"2.44","vol":"3.01"},{"date":"2024-09-30","value":"2.74","vol":"3.38"},{"date":"2024-06-30","value":"2.45","vol":"3.39"},{"date":"2024-03-31","value":"2.41","vol":"3.62"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
速动比率	2.26	2.44	2.74	2.45	2.41
行业	3.17	3.01	3.38	3.39	3.62

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/98 ， 45/98。

[{"date":"2025-03-31","value":"13.96","vol":"31.77"},{"date":"2024-12-31","value":"14.02","vol":"32.31"},{"date":"2024-09-30","value":"16.11","vol":"31.03"},{"date":"2024-06-30","value":"18.07","vol":"31.65"},{"date":"2024-03-31","value":"17.87","vol":"31.05"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资产负债率(%)	13.96	14.02	16.11	18.07	17.87
行业(%)	31.77	32.31	31.03	31.65	31.05

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.16","vol":"0.97"},{"date":"2024-12-31","value":"0.16","vol":"1.01"},{"date":"2024-09-30","value":"0.19","vol":"0.85"},{"date":"2024-06-30","value":"0.22","vol":"0.87"},{"date":"2024-03-31","value":"0.22","vol":"0.92"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
产权比率 (%)	0.16	0.16	0.19	0.22	0.22
行业(%)	0.97	1.01	0.85	0.87	0.92

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
中泰证券	2025-05-11	买入
国信证券	2025-05-09	买入	买入
国联民生	2025-05-06	买入	买入
华安证券	2025-04-07	增持
华西证券	2025-04-01	增持
光大证券	2025-03-31	增持

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"5.57","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"10.74","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.97","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.74","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.24","blueLineValue":"0.43","type":"YC"}]

[昭衍新药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]